Recursion Pharmaceuticals, Inc. SEC filings RXRX

Recursion Pharmaceuticals, Inc. has 991 filings in SEC EDGAR's recent list, going back to Apr 2, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Recursion Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 2, 2026 Oct 31, 2026
424B5 Prospectus supplement Oct 15, 2026 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
Oct 15, 2026 Oct 15, 2026
424B5 Prospectus supplement Oct 15, 2026 —
8-K Current report
Material agreement
Sep 21, 2026 Sep 15, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 30, 2026 Apr 28, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 25, 2026 Mar 25, 2026
S-8 Employee stock plan registration Feb 25, 2026 —
424B5 Prospectus supplement Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 25, 2026 Feb 25, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Dec 8, 2025 Dec 8, 2025
8-K Current report
Other events
Nov 26, 2025 Nov 26, 2025
424B7 Filing Nov 26, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 5, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K/A Amended current report
Unregistered share sale, Other events
Aug 29, 2025 Jul 8, 2025
424B7 Filing Aug 29, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2025 Aug 5, 2025
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Jul 8, 2025 Jul 8, 2025
424B7 Filing Jul 8, 2025 —
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 18, 2025
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Jun 10, 2025 Jun 10, 2025
8-K Current report
Other events
May 9, 2025 May 9, 2025
424B7 Filing May 9, 2025 —
S-8 Employee stock plan registration May 5, 2025 —
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Apr 28, 2025
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Mar 18, 2025 Mar 15, 2025
424B5 Prospectus supplement Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2025 Feb 28, 2025
S-3ASR Automatic shelf registration Feb 12, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Dec 17, 2024 Dec 17, 2024
424B7 Filing Dec 17, 2024 —
8-K Current report
Officer or director change
Dec 3, 2024 Dec 2, 2024
8-K/A Amended current report Nov 27, 2024 Nov 19, 2024
8-K/A Amended current report
Unregistered share sale
Nov 26, 2024 Aug 8, 2024
8-K Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure, Other events
Nov 20, 2024 Nov 19, 2024
S-8 Employee stock plan registration Nov 20, 2024 —
8-K Current report
Shareholder vote results
Nov 13, 2024 Nov 12, 2024
8-K Current report
Other events
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2024 Nov 6, 2024
DEFA14A Additional proxy material Nov 6, 2024 —
8-K Current report
Material agreement, Other events
Nov 6, 2024 Nov 5, 2024
DEFA14A Additional proxy material Oct 30, 2024 —
DEFM14A Filing Oct 10, 2024 —
8-K Current report
Regulation FD disclosure
Oct 2, 2024 Oct 2, 2024
DEFA14A Additional proxy material Sep 19, 2024 —
PREM14A Filing Sep 17, 2024 Sep 17, 2024
DEFA14A Additional proxy material Sep 4, 2024 —
DEFA14A Additional proxy material Sep 3, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 3, 2024 Sep 3, 2024
DEFA14A Additional proxy material Aug 28, 2024 —
8-K Current report
Other events
Aug 28, 2024 Aug 28, 2024
DEFA14A Additional proxy material Aug 9, 2024 —
DEFA14A Additional proxy material Aug 8, 2024 —
DEFA14A Additional proxy material Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Officer or director change, Regulation FD disclosure
Aug 8, 2024 Aug 6, 2024
8-K Current report
Other events
Aug 6, 2024 Aug 6, 2024
424B5 Prospectus supplement Jun 27, 2024 —
8-K Current report
Other events
Jun 27, 2024 Jun 26, 2024
424B5 Prospectus supplement Jun 26, 2024 —
8-K Current report
Regulation FD disclosure
Jun 24, 2024 Jun 24, 2024
UPLOAD Letter from the SEC Jun 13, 2024 —
CORRESP Letter to the SEC Jun 13, 2024 —
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 3, 2024
UPLOAD Letter from the SEC May 30, 2024 —
DEFA14A Additional proxy material May 24, 2024 —
8-K Current report
Auditor change, Officer or director change, Regulation FD disclosure
May 24, 2024 May 21, 2024
S-8 Employee stock plan registration May 10, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations, Auditor change, Regulation FD disclosure
May 9, 2024 May 7, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 3, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 16, 2024 Apr 15, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
8-K Current report
Officer or director change
Feb 7, 2024 Feb 6, 2024
8-K Current report
Bylaw or fiscal year change
Jan 31, 2024 Jan 25, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure
Dec 20, 2023 Dec 20, 2023
8-K Current report
Other events
Dec 15, 2023 Dec 15, 2023
424B7 Filing Dec 15, 2023 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Nov 9, 2023 Nov 9, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 2, 2023 Sep 28, 2023
8-K Current report
Regulation FD disclosure
Sep 5, 2023 Sep 5, 2023
8-K/A Amended current report
Shareholder vote results
Aug 11, 2023 Jun 16, 2023
424B5 Prospectus supplement Aug 8, 2023 —
424B7 Prospectus [rule 424(b)(7)] Aug 8, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 12, 2023 Jul 11, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 16, 2023
8-K Current report
Regulation FD disclosure
Jun 13, 2023 Jun 13, 2023
8-K Current report
Other events
Jun 9, 2023 Jun 9, 2023
424B5 Prospectus supplement Jun 9, 2023 —
S-8 Employee stock plan registration May 30, 2023 —
S-3ASR Automatic shelf registration May 30, 2023 —
8-K Current report
Regulation FD disclosure
May 25, 2023 May 25, 2023
S-8 Employee stock plan registration May 18, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
May 17, 2023 May 16, 2023
S-8 Employee stock plan registration May 8, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2023 May 8, 2023
8-K Current report
Unregistered share sale, Regulation FD disclosure
May 8, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-K Annual report Feb 27, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2023 Feb 27, 2023
8-K Current report
Other events
Jan 25, 2023 Jan 25, 2023
8-K Current report
Regulation FD disclosure
Jan 13, 2023 Jan 13, 2023
8-K Current report
Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2022 Nov 8, 2022
424B3 Prospectus Oct 28, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Oct 25, 2022 Oct 24, 2022
8-K Current report
Other events
Sep 13, 2022 Sep 13, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2022 Aug 9, 2022
8-K Current report
Other events
Jun 21, 2022 Jun 20, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 14, 2022
8-K Current report
Officer or director change
Jun 9, 2022 Jun 7, 2022
S-8 Employee stock plan registration May 10, 2022 —
S-3ASR Automatic shelf registration May 10, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2022 May 10, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 14, 2022
8-K Current report
Other events
Apr 11, 2022 Apr 11, 2022
10-K Annual report Mar 23, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 23, 2022 Mar 23, 2022
8-K Current report
Other events
Mar 18, 2022 Mar 18, 2022
8-K Current report
Other events
Mar 3, 2022 Mar 3, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Material agreement
Dec 7, 2021 Dec 5, 2021
8-K Current report
Other events
Dec 6, 2021 Dec 2, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2021 Nov 10, 2021
8-K Current report
Other events
Oct 7, 2021 Oct 7, 2021
8-K Current report
Regulation FD disclosure
Sep 9, 2021 Sep 9, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 13, 2021
8-K Current report
Regulation FD disclosure
Jul 13, 2021 Jul 13, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 12, 2021 May 12, 2021
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Apr 21, 2021 Apr 20, 2021
S-8 Employee stock plan registration Apr 16, 2021 —
424B4 Prospectus Apr 16, 2021 —
SEC STAFF LETTER Filing Apr 15, 2021 —
EFFECT Filing Apr 15, 2021 —
S-1MEF Filing Apr 15, 2021 —
CERT Filing Apr 15, 2021 —
S-1/A Amended registration statement Apr 15, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
CORRESP Letter to the SEC Apr 13, 2021 —
S-1/A Amended registration statement Apr 12, 2021 —
8-A12B Filing Apr 12, 2021 —
SEC STAFF LETTER Filing Mar 25, 2021 —
CORRESP Letter to the SEC Mar 22, 2021 —
S-1 Registration statement Mar 22, 2021 —
UPLOAD Letter from the SEC Mar 19, 2021 —
DRSLTR Filing Mar 3, 2021 —
DRS/A Filing Mar 3, 2021 —
UPLOAD Letter from the SEC Feb 22, 2021 —
DRS Filing Jan 26, 2021 —
D/A Filing Nov 12, 2020 —
D Filing Sep 15, 2020 —
D Filing Aug 13, 2019 —
D Filing Oct 6, 2017 —
D/A Filing Dec 2, 2016 —
D Filing Sep 14, 2016 —
D Filing Sep 14, 2016 —
D Filing Sep 14, 2016 —
D Filing Dec 4, 2015 —
D Filing Feb 23, 2015 —
D/A Filing Apr 2, 2014 —
D Filing Apr 2, 2014 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
RXRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Large accelerated filer
SEC CIK
1601830
Former names
Recursion Pharmaceuticals, LLC (until Dec 4, 2015)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.